Bavarian Nordic A/S is a Pharmaceuticals company based in Denmark with a medium risk ESG score of 23.1. Specializing in biotechnology, the company is dedicated to creating and distributing life-saving vaccines worldwide. Key products include Encepur, Jynneos, Rabipur, Vaxchora, and Vivotif, with a focus on sustainability and governance practices.